id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0114-0007,FDA,FDA-2011-E-0114,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2024-03-13T11:58:33Z,,0,0,090000648119c7dd
FDA-2011-E-0114-0006,FDA,FDA-2011-E-0114,Determination of Patent Extension Regulatory Review Period; Victoza,Notice,General Notice,2012-05-02T04:00:00Z,2012,5,2012-05-02T04:00:00Z,2012-07-03T03:59:59Z,2012-05-02T20:09:15Z,2012-10517,0,0,09000064810033cc
FDA-2011-E-0114-0005,FDA,FDA-2011-E-0114,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-04-17T04:00:00Z,2012,4,2012-04-17T04:00:00Z,,2024-03-13T11:58:17Z,,0,0,0900006480ff2a5f
FDA-2011-E-0114-0004,FDA,FDA-2011-E-0114,Letter to U. S. Patent & Trademark Office,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2024-03-13T17:30:18Z,,0,0,0900006480f91f90